FIELD: medicine.
SUBSTANCE: to increase oxygen tension in blood of a patient with the chronic heart failure, antioxidant medication of ethylmethylhydroxypyridine malate in an amount of 50-200 mg is introduced to the patient one time.
EFFECT: improved indices of the oxygen-transport function of blood in the patients with diagnosis of the chronic heart failure without disturbance of feedback between tension of oxygen in blood and the content of 2,3-DPG in blood.
1 tbl, 3 ex, 1 dwg
| Title | Year | Author | Number | 
|---|---|---|---|
| METHOD FOR ACTIVATING P450CYP3A4 ISOENZYME IN PATIENTS WITH CHRONIC CARDIAC FAILURE | 2014 | 
 | RU2554775C1 | 
| METHOD OF TREATING ISCHEMIC HEART DISEASES ACCOMPANYING CHOLESTASIS | 2014 | 
 | RU2554333C1 | 
| METHOD FOR TREATING CHRONIC HEART FAILURE | 2005 | 
 | RU2304964C2 | 
| METHOD FOR IDENTIFICATION LONG-TERM MORTALITY RISK AND NEFTAL CARDIOVASCULAR COMPLICATIONS IN PATIENTS WITH CHRONIC ISCHEMIC HEART DISEASE | 2017 | 
 | RU2649964C1 | 
| METHOD OF TREATING PATIENTS SUFFERING ARTERIAL HYPERTENSION | 2012 | 
 | RU2508087C1 | 
| METHOD FOR PREDICTING CLINICAL COURSE OF CHRONIC HEART FAILURE IN PATIENTS WITH ISCHEMIC HEART DISEASE | 2024 | 
 | RU2828974C1 | 
| METHOD FOR TREATING PATIENTS WITH CHRONIC HEART FAILURE AT THE BACKGROUND OF ISCHEMIC CARDIAC DISEASE | 2000 | 
 | RU2213559C2 | 
| METHOD FOR PREDICTION OF RISK OF FATAL OUTCOME IN COMORBID PATIENTS WITH CHRONIC HEART FAILURE | 2024 | 
 | RU2838522C1 | 
| PREPARATION FOR COMPLEX THERAPY OF DISEASES CAUSED BY BETA-CORONAVIRUSES | 2020 | 
 | RU2739212C1 | 
| METHOD FOR EVALUATING RISK OF REMOTE DEATH AND NONFATAL CARDIOVASCULAR COMPLICATIONS IN PATIENTS WITH CHRONIC ISCHEMIC HEART DISEASE | 2014 | 
 | RU2570089C1 | 
Authors
Dates
2014-08-20—Published
2013-07-30—Filed